Grown Rogue Delays 2025 Financials Amid IFRS-to-GAAP Transition
Event summary
- Grown Rogue rescheduled its full 2025 financial results release to April 7, 2026, citing complexity in transitioning from IFRS to U.S. GAAP.
- Preliminary 2025 revenue grew 22% YoY to $32.4M, with Adjusted EBITDA up 39% to $5.3M.
- New Jersey operations contributed $11.3M in revenue, offsetting declines in Oregon (-8%) and Michigan (-22%).
- Cash and cash equivalents more than doubled to $11.4M, partly due to debt financing.
The big picture
Grown Rogue's delay highlights the operational challenges of transitioning accounting standards while expanding into new markets. The company's strong preliminary results underscore the potential of its New Jersey operations, but pricing pressures in existing markets pose a strategic balancing act. The cannabis industry's competitive dynamics will test Grown Rogue's ability to scale its flower-forward model efficiently.
What we're watching
- Execution Risk
- Whether Grown Rogue can sustain its growth trajectory in New Jersey while managing pricing pressures in mature markets like Oregon and Michigan.
- Regulatory Compliance
- The pace at which the company can complete its IFRS-to-GAAP transition without further delays or material adjustments.
- Market Expansion
- How the company's initiatives in Illinois and Minnesota will contribute to its 2026 growth outlook.
Related topics